NYMC Faculty Publications
Zeaxanthin Induces Apoptosis in Human Uveal Melanoma Cells Through Bcl-2 Family Proteins and Intrinsic Apoptosis Pathway
Author Type(s)
Faculty
DOI
10.1155/2013/205082
Journal Title
Evidence-Based Complementary and Alternative Medicine
First Page
205082
Last Page
205082
Document Type
Article
Publication Date
1-1-2013
Abstract
The cytotoxic effects of zeaxanthin on two human uveal melanoma cell lines (SP6.5 and C918) and related signaling pathways were studied and compared to effects on normal ocular cells (uveal melanocytes, retinal pigment epithelial cells, and scleral fibroblasts). MTT assay revealed that zeaxanthin reduced the cell viability of melanoma cells in a dose-dependent manner (10, 30, and 100 μ M), with IC50 at 40.8 and 28.7 μ M in SP6.5 and C918 cell lines, respectively. Zeaxanthin did not affect the viability of normal ocular cells even at the highest levels tested (300 μ M), suggesting that zeaxanthin has a selectively cytotoxic effect on melanoma cells. Zeaxanthin induced apoptosis in melanoma cells as indicated by annexin V and ethidium III flow cytometry. Western blot analysis demonstrated that zeaxanthin decreased the expression of antiapoptotic proteins (Bcl-2 and Bcl-xL) and increased the expression of proapoptotic proteins (Bak and Bax) in zeaxanthin-treated melanoma cells. Zeaxanthin increased mitochondrial permeability as determined by JC-1 fluorescein study. Zeaxanthin also increased the level of cytosol cytochrome c and caspase-9 and -3 activities, but not caspase-8, as measured by ELISA assay or colorimetric assay. All of these findings indicate that the intrinsic (mitochondrial) pathway is involved in zeaxanthin-induced apoptosis in uveal melanoma cells.
Recommended Citation
Bi, M., Rosen, R., Zha, R., McCormick, S., Song, E., & Hu, D. (2013). Zeaxanthin Induces Apoptosis in Human Uveal Melanoma Cells Through Bcl-2 Family Proteins and Intrinsic Apoptosis Pathway. Evidence-Based Complementary and Alternative Medicine, 2013, 205082-205082. https://doi.org/10.1155/2013/205082